EDGAR Filing Documents for 0001564590-17-011020

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001564590-17-011020

Filing Date

2017-05-15

Accepted

2017-05-15 16:05:12

Documents

Period of Report

2017-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	srne-10q_20170331.htm	10-Q	1532295
2	EX-10.3	srne-ex103_472.htm	EX-10.3	83891
3	EX-10.4	srne-ex104_473.htm	EX-10.4	30734
4	EX-10.5	srne-ex105_471.htm	EX-10.5	152487
5	EX-31.1	srne-ex311_6.htm	EX-31.1	9648
6	EX-31.2	srne-ex312_12.htm	EX-31.2	9594
7	EX-32.1	srne-ex321_7.htm	EX-32.1	10941
	Complete submission text file	0001564590-17-011020.txt		8847561

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	srne-20170331.xml	EX-101.INS	1717245
9	XBRL TAXONOMY EXTENSION SCHEMA	srne-20170331.xsd	EX-101.SCH	83349
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	srne-20170331_cal.xml	EX-101.CAL	63043
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	srne-20170331_def.xml	EX-101.DEF	353518
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE	srne-20170331_lab.xml	EX-101.LAB	629492
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	srne-20170331_pre.xml	EX-101.PRE	535811

Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121

Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700

Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)